Pathogenesis of allergic rhinitis.
Allergic rhinitis is an increasing problem for which new and exciting therapies are being developed. These can be understood through an appreciation of the newer concepts of pathogenesis of allergic rhinitis. Allergen induces Th2 lymphocyte proliferation in persons with allergies with the release of their characteristic combination of cytokines including IL-3, IL-4, IL-5, IL-9, IL-10, and IL-13. These substances promote IgE and mast cell production. Mucosal mast cells that produce IL-4, IL-5, IL-6, and tryptase proliferate in the allergic epithelium. Inflammatory mediators and cytokines upregulate endothelial cell adhesion markers, such as vascular cell adhesion molecule-1. Chemoattractants, including eotaxin, IL-5, and RANTES, lead to characteristic infiltration by eosinophils, basophils, Th2 lymphocytes, and mast cells in chronic allergic rhinitis. As our understanding of the basic pathophysiologic features of allergic rhinitis continues to increase, the development of new diagnostic and treatment strategies may allow more effective modulation of the immune system, the atopic disease process, and the associated morbidity.
Baraniuk
J N
JN
Department of Medicine, Georgetown University, Washington, DC 20007-2197, USA.
D000485:Allergens / Q000276:immunology; D017951:Antigen Presentation; D001491:Basophils / Q000276:immunology; D002448:Cell Adhesion / Q000502:physiology; D002465:Cell Movement; D054413:Chemokine CCL11; D018946:Chemokine CCL5 / Q000502:physiology; D019742:Chemokines, CC; D053818:Chymases; D016207:Cytokines / Q000502:physiology; D004804:Eosinophils / Q000276:immunology; D006632:Histamine / Q000502:physiology; D006801:Humans; D007114:Immunization; D007073:Immunoglobulin E / Q000096:biosynthesis; D007378:Interleukins / Q000276:immunology; D008407:Mast Cells / Q000378:metabolism / Q000502:physiology; D012221:Rhinitis, Allergic, Perennial / Q000276:immunology* / Q000503:physiopathology* / Q000628:therapy; D006255:Rhinitis, Allergic, Seasonal / Q000276:immunology* / Q000503:physiopathology* / Q000628:therapy; D012697:Serine Endopeptidases / Q000096:biosynthesis; D018418:Th2 Cells / Q000276:immunology; D053802:Tryptases; D015854:Up-Regulation; D019010:Vascular Cell Adhesion Molecule-1 / Q000378:metabolism
D000485:Allergens; C515456:CCL11 protein, human; D054413:Chemokine CCL11; D018946:Chemokine CCL5; D019742:Chemokines, CC; D016207:Cytokines; D007378:Interleukins; D019010:Vascular Cell Adhesion Molecule-1; D007073:Immunoglobulin E; D006632:Histamine; D012697:Serine Endopeptidases; C083294:chymase 2; D053818:Chymases; D053802:Tryptases